Global Prenatal And New-Born Genetic Testing Market
Prenatal and Newborn Genetic Testing Market Size And Forecast
The Global Prenatal and Newborn Genetic Testing Market was valued at USD 4.17 Billion in 2019 and is projected to reach USD 11.23 Billion by 2027, growing at a CAGR of 13.46% from 2020 to 2027.
Global Prenatal and Newborn Genetic Testing Market Outlook
The market for Prenatal and NewBorn Genetic Testing is anticipated to grow at a significant rate during the forecast period owing to the growing prevalence of chromosomal abnormalities and genetic disorders among new-born babies. It has been found that every year 8 million children are born with a serious birth defect either of genetic or partially genetic origin and it represents 6% of the total births worldwide. The newborn screening programs play a vital role to identify various genetic disorders among newborn babies to deliver medical intervention before these symptoms develop.
Global Prenatal and Newborn Genetic Testing Market: Segmentation Analysis
The Global Prenatal and Newborn Genetic Testing Market is segmented on the basis of technology, end-use, disease, and geography.
Global Prenatal and Newborn Genetic Testing Market Competitive Landscape
The “Global Prenatal and Newborn Genetic Testing Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Abbott Laboratories, Bio-Rad Laboratories, Inc., Qiagen N.V., Natera, Inc, Illumina, Inc., and Others.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.